ICP4 is a herpesvirus-encoded protein that is expressed during the immediate-early phase of productive infection and is required for efficient transcription of viral genes during the early and late phases of infection. Previous studies have shown that ICP4 is a component of specific protein-DNA complexes but have not revealed whether native ICP4 directly recognizes specific nucleotide sequences. Using DNA affinity chromatography, we have purified ICP4 to near homogeneity. The purified preparation consists primarily of dimeric and tetrameric forms of ICP4. As shown by DNase protection experiments, purified ICP4 binds directly to specific sequences in viral DNA. The stability of ICP4-DNA complexes is increased over 100-fold by shifting the temperature from 23 to 4°C. The equilibrium dissociation constant of ICP4-DNA complexes formed at 4°C in the presence of 100 mM NaCI was determined to be approximately 1.1 nM. (4, 7, 8, 10, 11, 16, 18, 21, 22, 28, 35-37, 40, 45). The temporal pattern of expression for a given viral gene forms the basis for its classification as either an immediate-early (alpha), early (beta), or late (gamma) gene (6, 18, 19, 48).
ICP4 is a herpesvirus-encoded protein that is expressed during the immediate-early phase of productive infection and is required for efficient transcription of viral genes during the early and late phases of infection. Previous studies have shown that ICP4 is a component of specific protein-DNA complexes but have not revealed whether native ICP4 directly recognizes specific nucleotide sequences. Using DNA affinity chromatography, we have purified ICP4 to near homogeneity. The purified preparation consists primarily of dimeric and tetrameric forms of ICP4. As shown by DNase protection experiments, purified ICP4 binds directly to specific sequences in viral DNA. The stability of ICP4-DNA complexes is increased over 100-fold by shifting the temperature from 23 to 4°C. The equilibrium dissociation constant of ICP4-DNA complexes formed at 4°C in the presence of 100 mM NaCI was determined to be approximately 1.1 nM.
The genome of herpes simplex virus (HSV) contains approximately 152 kilobase pairs (kbp) and at least 70 genes (30) . During the course of productive infection, transcription of viral genes is temporally and quantitatively regulated by cis-acting signals within the viral genome and by trans-acting factors encoded in both the host and viral genomes (4, 7, 8, 10, 11, 16, 18, 21, 22, 28, 35-37, 40, 45) . The temporal pattern of expression for a given viral gene forms the basis for its classification as either an immediate-early (alpha), early (beta), or late (gamma) gene (6, 18, 19, 48) .
One of the five immediate-early genes encodes a polypeptide designated ICP4 (a4 or IE175k), which acts as a positive regulator of early gene transcription and a negative regulator of ICP4 gene transcription (8, 9, 17, 37, 39. 47) . Proposed mechanisms for ICP4-mediated induction or repression of viral gene transcription include (i) ICP4-dependent activation or inactivation of cell-encoded transcription factors, (ii) ICP4-dependent modification of RNA polymerase II, and (iii) formation of specific ICP4-DNA complexes (9) . Direct tests of mechanism 1 have not been reported. With regard to mechanism 2, Beck and Millette (2) observed that RNA polymerase II from HSV-infected cells has altered chromatographic and enzymatic properties, but the molecular basis for these alterations has not been established. Relevant to mechanism 3 are reports by several investigators that incubation of radiolabeled DNA with HSV-infected cell extracts (24, 25, 34) or partially purified preparations of ICP4 (1, 12, 14, 32) can result in the formation of stable protein-DNA complexes that contain ICP4 and specific viral DNA sequences.
We have described a method for partial purification of ICP4 from HSV type 1 (HSV-1)-infected Vero cells (12 General methods. Protein concentrations were measured by a modification of the Lowry method (27) with bovine serum albumin (BSA) as a standard. Spot dot radioimmunoassays for ICP4 were performed as previously described (31) . Plasmid DNA was prepared by the method of Birnboim and Doly (3). Calf thymus DNA (Sigma Chemical Co.) was extracted twice with phenol-chloroform (1:1), precipitated with ethanol, suspended in buffer TE (see below), and sonicated to an average chain length of 300 bp. Polypeptides were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described previously (31) . Before gel electrophoresis, protein samples from column fractions were precipitated by the addition of trichloroacetic acid to 10% (wt/vol); the precipitate was pelleted at 12,000 x g for 15 min, suspended by sonication in 0.25 M NaOH, and then diluted by addition of an equal volume of 2x buffer DB (see below).
Buffers. Buffer C contained 10 Construction of pXK13. We are indebted to Tom Kelly for introducing us to the logic of the following construction (42) . All plasmids were propagated in E. coli HB101, which is a recA mutant. From a PstI-BamHI digest of pAT153/Bgl, we isolated a 1,127-bp fragment that included the two ICP4-protein-binding sites. From a PstI-BglII digest of pAT153/ Bgl, we isolated a 2,957-bp fragment that included the two ICP4-protein-binding sites. These two fragments were ligated together (the BamHI and BglII termini are complementary) to yield pXK444-2, which has unique PstI, BglII, and BamHI sites and a head-to-tail repeat of the 346-bp region derived from pAT153/Bgl that spans two ICP4-protein-binding sites. From pXK444-2 we isolated the PstI-BglII and PstI-BamHI fragments that span the head-to-tail repeat of the ICP4-protein-binding sites. These two fragments were ligated to yield pXK444-4, which contains four copies, as head-to-tail repeats, of the 346-bp region derived from pAT153/Bgl. This process was continued until we obtained pXK444-32, which contains 32 copies of the 346-bp BglIIBamHI region from pAT153/Bgl and thus contains 64 ICP4-protein-binding sites. Plasmid pXK444-32 was digested with EcoRI and Sall, and the 11.38-kbp fragment containing the ICP4-protein-binding sites was inserted between the EcoRI and SalI sites in the high-copy-number vector pUC13 to yield pXK13. Transformants of HB101 were subcloned and screened to isolate a strain in which pXK13 was maintained as a 14-kbp plasmid.
Preparation of affinity DNA-cellulose. DNA was adsorbed to cellulose by the method of Litman (26) with the following modifications. Plasmid pXK13 was linearized by digestion with EcoRI, extracted with phenol, precipitated with ethanol, and suspended in 10 mM NaCl at 2 mg/ml. Acid-washed cellulose (0.375 g/ml of DNA solution) was added and mixed to yield a thick paste which was dried at 37°C for 24 h. The dried cellulose was ground to a fine powder and washed for 10 min at 20°C once with 100% ethanol, twice with 10 mM NaCI, and once with buffer C supplemented with 50 mM KCI. The washed DNA-cellulose was suspended in buffer C supplemented with 50 mM KCI to yield a matrix with approximately 2.7 mg of DNA bound per g of cellulose.
Purification of ICP4. All operations were carried out at 0 to 4°C. All buffers were treated with N-tosyl-L-phenylalanine chloromethyl ketone immediately before use. A high-salt extract from the nuclei of 8 x 109 HSV-1-infected Vero cells was prepared as described previously (31) . Briefly, nuclei were isolated by disruption of infected cells in hypotonic buffer. Adhering membranes were removed with Triton X-100. The washed nuclei were disrupted by sonication in buffer C containing 300 mM (NH4)2SO4. This extract was clarified by centrifugation at 100,000 x g for 1 h. Proteins in the supernatant were precipitated by addition of (NH4)2SO4 to 50% saturation. The precipitated protein was suspended in buffer C supplemented with 300 mM (NH4)2SO4 and lacking glycerol, clarified by brief centrifugation, and designated fraction V.
Fraction V was applied to a Sephacryl S-400 column (2.5 by 57 cm) equilibrated in buffer C supplemented with 300 mM (NH4)2SO4 and lacking glycerol. Protein was eluted with buffer C supplemented with 300 mM (NH4)2SO4 and lacking glycerol at a flow rate of 15.0 ml/h. Fractions of 3.0 ml were collected and assayed for ICP4 by spot dot radioimmunoassay and SDS-PAGE. Fractions enriched in ICP4 were pooled. Pooled proteins were precipitated by addition of (NH4)2SO4 to 50% saturation and suspended in buffer C supplemented with 300 mM (NH4)2SO4 to yield fraction VI.
Fraction VI was dialyzed against buffer C supplemented with 50 mM KCl. The resulting precipitate was removed by centrifugation at 16 ,000 x g for 10 min. The supernatant, designated fraction VII, was loaded onto a DEAE-TrisAcryl M column (1.3 by 4.7 cm) equilibrated in buffer C supplemented with 50 mM KCl. Protein was eluted at a flow rate of 5 mI/h with a linear gradient of 50 to 350 mM KCl in buffer C; this step was followed by a step wash with 500 mM KCI in buffer C. Fractions enriched in ICP4 were pooled. Pooled proteins were precipitated by addition of (NH4)2SO4 to 50% saturation and suspended in buffer C supplemented with 50 mM KCI to yield fraction VIII.
Fraction VIII was dialyzed against buffer C supplemented with 50 mM KCI and loaded onto a pXK13 affinity DNAcellulose column (1.3 by 4.7 cm) equilibrated in buffer C supplemented with 50 mM KCI. Protein was eluted with a linear gradient of 50 to 1,500 mM KCl in buffer C; this was followed by a step wash with 2.0 M KCl in buffer C.
Fractions enriched in ICP4 were pooled. Pooled proteins were precipitated by addition of (NH4)2SO4 to 50% saturation and suspended in 10 mM Tris hydrochloride (pH 8.0)-i mM EDTA-10 mM 2-mercaptoethanol-50% glycerol. This preparation was designated fraction IX and stored at -80°C. 25 -mm nitrocellulose disk (BA-85; Schleicher & Schuell, Inc.) which had been boiled twice for 10 min in distilled water and then chilled. The sample was filtered at a controlled rate of 0.5 ml/min at 4°C. The filter was then washed three times with 0.5 ml of ice-cold buffer DNAP lacking BSA. The washed filter was dried, and the amount of bound radiolabeled DNA was determined by scintillation counting.
RESULTS Purification of ICP4. The ICP4 purification scheme is described in detail in Materials and Methods, and results are presented in Fig. 1 . Nuclei prepared from HSV-1-infected Vero cells were washed with Triton X-100 to remove membranes and adhering cytoplasmic components. The detergent-washed nuclei (fraction III) contained more than 85% of the cell-associated ICP4 (estimated from radioimmunoassays) and less than 22% of the total cell protein ( Table 1) . The nuclei were disrupted by sonication and clarified by centrifugation. Most of the protein in the supernatant was precipitated by the addition of ammonium sulfate, whereas most of the nucleic acid remained soluble. The precipitated protein was suspended in a solution with an ionic strength greater than 0.5 M for optimal recovery of ICP4 in fraction V.
Fraction V was chromatographed through a molecular sieve matrix equilibrated in a high-ionic-strength buffer to Fraction VIII was loaded onto a DNA affinity matrix consisting of plasmid pXK13 bound to cellulose. This plasmid consists of 64 concatenated ICP4-protein-binding sites arranged in a head-to-tail orientation in the vector pUC13. The ICP4 in fraction VIII bound quantitatively to the column and was eluted with a gradient of KCl (Fig. 3) . The ICP4 in fractions containing 325 to 490 mM KCl was pooled, concentrated by ammonium sulfate precipitation, and suspended in buffer to yield a solution designated fraction IX. It should be noted that ammonium sulfate precipitation of the pooled fractions from the DNA-cellulose column separates ICP4 from any DNA that may have leached from the column. Analysis of the polypeptides in fraction IX by SDS-PAGE revealed a nearly homogeneous 175,000-dalton polypeptide (Fig. 4A ) that reacts with antibody specific for ICP4 (13) (Fig. 4B) . A minor amount of ICP4 was also observed at a position corresponding to approximately 350,000 daltons (Fig. 4B) .
Characterization of the ICP4 in fraction IX. We previously reported (31) that native ICP4 present in fraction VII is a noncovalent homodimeric molecule with a sedimentation coefficient of 9.0S. Analysis of the sedimentation coefficient of the ICP4 in fraction IX by sucrose gradient centrifugation revealed two immunoreactive peaks (Fig. 5) . The major peak at 9.3S corresponds to the dimeric form of ICP4. Although the structure of the ICP4 in the more rapidly migrating peak at 14.2S has not been established, the sedimentation rate is consistent with a tetrameric form of ICP4. This result demonstrates that at least two different oligomeric forms of trimeric form suggests that ICP4 oligomers are formed by associations between dimers.
Sequence specificity of purified ICP4. The DNA-binding properties of the ICP4 in fraction IX were investigated by using a variety of target DNAs and binding conditions (P. Kattar-Cooley and K. W. Wilcox, manuscript submitted for publication). The results of these studies revealed that binding of ICP4 to specific target DNAs occurs at 4 to 37°C in a buffered (pH 7.5) solution containing 100 mM NaCl. The target DNA that was used for most of these experiments contained the region from -128 to +57 relative to the transcription initiation site for the HSV-1 gene that encodes ICPO (aO or IEllOk) (Fig. 6 ). It has been reported (25) that addition of this target DNA to a crude extract from HSVinfected cells results in formation of a protein-DNA complex that includes ICP4 and that protects nucleotides -71 to -46 of the ICPO promoter from digestion by exonuclease III. To determine whether ICP4 alone is sufficient to protect nucleotides -71 to -46 of the ICPO promoter from nucleolytic digestion, an end-labeled 233-bp fragment (Fig. 6 ) that contains the ICPO gene promoter region was incubated with fraction IX and then briefly exposed to DNase I. We observed (Fig. 7) that the region from approximately -72 to -49 was protected by ICP4. This corresponds to essentially the same region protected by a crude preparation of ICP4 (25) 3' that has been observed in all reported footprints produced by ICP4 (14 binding reaction reached equilibrium, a 10-fold excess of unlabeled specific competitor DNA (pXK13) was added as a "sink" for free ICP4; protein-bound radiolabeled DNA was quantitated at intervals thereafter by nitrocellulose filtration. We observed that both the rate and apparently the order of the dissociation reaction were different at the two temperatures. Of the bound DNA, 50% dissociated from the complexes within 5 min at 23°C (Fig. 8A) , whereas at 4°C the half-life of the complexes was approximately 35 h (Fig. 8B) . At 4°C the dissociation reaction was first order, whereas at 23°C the dissociation rate apparently varied with both time and concentration. Thus, it appears that temperature may have a profound effect on both the stability and the structure of ICP4-DNA complexes. To simplify interpretation of the data, we chose to measure additional kinetic parameters at 40C.
Binding affinity of pure ICP4 for a specific DNA sequence. If it is assumed that formation of ICP4-DNA complexes proceeds by a bimolecular reaction in which freely diffusible molecules of ICP4 and DNA form specific complexes, then the ratio of protein-bound DNA to free DNA when the binding reaction is at equilibrium provides an indication of the relative affinity of ICP4 for that specific target DNA under a defined set of conditions (41) . By obtaining measurements of PD/D (where PD is the amount of protein-bound DNA and D is the amount of free DNA) over a range of initial DNA concentrations, the equilibrium constant (KD) for the binding reaction between ICP4 and a specific target DNA may be determined (43) . This procedure also provides information on the amount of active ICP4 present in a binding reaction. The results of such an analysis are shown in Fig. 9 . In Fig. 9A Discussion) .
The data shown in Fig. 9A can be represented in an alternative format, as described by Scatchard (43) , by plotting PD/D versus PD. In this format, the slope of the line is equal to the negative inverse of the equilibrium dissociation constant (KD) and the x intercept is equal to the molar concentration of active ICP4 in the reaction. From this representation of the data (Fig. 9B) (38) . It has been l a calculated equilibrium dissociation constant of 1.1 proposed that these structural variants have the same priconcentration of total binding protein was calculated mary amino acid sequence but differ in the number and wept with the abscissa. location of phosphate and/or other moieties added posttranslationally (49) . It is tempting to speculate that these structural variants represent functional variants of ICP4. Analysis of (41) or phage lambda cI protein (3 x 10-13 M) ICP4-DNA complexes by the Southwestern (DNA-protein) imilar to the KD value for complexes formed blot procedure (32) suggests that both the b and the c forms of A and either simian virus 40 T antigen (0.4 x ICP4 can bind DNA (the a form was not resolved in this 10-9) (33) or the E. coli tryptophan (trp) experiment), although specificity of binding may differ some-6 x 10-9 M) (23, 44) . Direct comparisons among what between the two forms. It should be noted that the iation constants are inappropriate because the migration profile of ICP4 in an SDS gel is strain dependent; in determined under different binding conditions. particular, ICP4 present in extracts from cells infected with rom preliminary results (Kattar-Cooley and the HFEM strain of HSV-1 migrates as a single broad band on iblished results), it is clear that assay conditions SDS gels (31) . The ICP4 in fraction IX was obtained from )t sufficient to explain the relatively high KD HFEM-infected cells and migrates as a single broad band [CP4-DNA complexes compared with either during SDS-PAGE (Fig. 4) . Furthermore, we presume that NA or lac repressor-DNA complexes.
the ICP4 in fraction IX is heterogeneous with respect to alue for a given protein-DNA complex is inphosphorylated forms. Thus, our results do not address the ortional to the strength and number of specific issue of binding affinities of different forms of ICP4.
between the protein and DNA. Both the lambda Our value for the molar concentration of ICP4 in binding *essors bind as oligomeric proteins that make assays is based on a measurement of the total protein itacts with symmetrical sites in DNA. The concentration in fraction IX, an estimate (from a Coomassieotein binds as a dimer to DNA (5) ; each of the stained gel) that greater than 90% of the protein mass in rs makes specific contact with a separate halffraction IX is ICP4, and the assumption that all of the ICP4 )ximately 8 bp. The lac repressor binds as a exists as a dimer under the conditions of the binding assay. DNA (15) ; at least two of the four protomers
We presume that this value is within a factor of 2 of the c contacts with separate half-sites of approxiactual value. Data from the Scatchard plot (Fig. 9) imply that each. Although ICP4 also binds to DNA in vitro approximately 45% of the ICP4 in fraction IX is capable of That a significant proportion of the ICP4 in fraction IX is able to bind to DNA is not unexpected, since the last step of the purification procedure is selective for this population.
More important is the observation that the ICP4 in fraction VIII bound quantitatively to the DNA-cellulose column (data not shown). If it is assumed that the first eight steps in the purification of ICP4 are not selective with respect to the DNA-binding ability of ICP4, then this would suggest that at least 22% of the ICP4 present in HSV-infected cells 6 h postinfection is capable of binding to DNA.
